RHUMBLINE ADVISERS - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,564,970
-55.8%
76,044
+1.0%
0.00%
-50.0%
Q2 2023$3,538,725
+98088.8%
75,260
-12.4%
0.00%0.0%
Q1 2023$3,604
+12.4%
85,893
+2.2%
0.00%0.0%
Q4 2022$3,205
-99.9%
84,034
+1.7%
0.00%
-20.0%
Q3 2022$3,234,000
+29.7%
82,594
+7.0%
0.01%
+25.0%
Q2 2022$2,493,000
+77.9%
77,189
+82.4%
0.00%
+100.0%
Q1 2022$1,401,000
-31.2%
42,324
-11.5%
0.00%0.0%
Q4 2021$2,035,000
-3.8%
47,848
+0.2%
0.00%
-33.3%
Q3 2021$2,116,000
-28.4%
47,756
-8.2%
0.00%
-25.0%
Q2 2021$2,956,000
-28.8%
52,041
-6.1%
0.00%
-33.3%
Q1 2021$4,150,000
-16.7%
55,445
-3.7%
0.01%
-14.3%
Q4 2020$4,981,000
+44.1%
57,575
+1.8%
0.01%
+40.0%
Q3 2020$3,457,000
+44.4%
56,565
-1.8%
0.01%
+25.0%
Q2 2020$2,394,000
+62.7%
57,575
+12.4%
0.00%
+33.3%
Q1 2020$1,471,000
-60.8%
51,224
-1.4%
0.00%
-50.0%
Q4 2019$3,750,000
-47.3%
51,940
+2.3%
0.01%
-53.8%
Q3 2019$7,122,000
-23.7%
50,768
-0.5%
0.01%
-27.8%
Q2 2019$9,340,000
+20.6%
51,012
+4.8%
0.02%
+20.0%
Q1 2019$7,743,000
+72.3%
48,684
+3.8%
0.02%
+50.0%
Q4 2018$4,493,000
-34.2%
46,907
-3.0%
0.01%
-23.1%
Q3 2018$6,828,000
-11.5%
48,337
-1.9%
0.01%
-18.8%
Q2 2018$7,711,000
+16.9%
49,262
+20.3%
0.02%
+14.3%
Q1 2018$6,597,000
+4.0%
40,955
+6.3%
0.01%
+7.7%
Q4 2017$6,346,000
+140.4%
38,526
-9.1%
0.01%
+116.7%
Q3 2017$2,640,000
-19.4%
42,371
+3.0%
0.01%
-14.3%
Q2 2017$3,276,000
+22.7%
41,138
+9.4%
0.01%
+16.7%
Q1 2017$2,671,000
+44.8%
37,587
+4.0%
0.01%
+20.0%
Q4 2016$1,845,000
+38.3%
36,129
+24.8%
0.01%
+25.0%
Q3 2016$1,334,000
+82.0%
28,959
+19.0%
0.00%
+100.0%
Q2 2016$733,000
+49.6%
24,337
+59.2%
0.00%0.0%
Q1 2016$490,000
-37.9%
15,290
+13.0%
0.00%
-33.3%
Q4 2015$789,000
+53.5%
13,535
+11.4%
0.00%
+50.0%
Q3 2015$514,000
-39.4%
12,155
+4.7%
0.00%
-33.3%
Q2 2015$848,00011,6100.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders